Momentum Bioscience


Momentum Bioscience is dedicated to creating innovative solutions for rapid diagnosis of bloodstream infections and sepsis. Their flagship product, SepsiSTAT®, aims to significantly reduce the time for microbial identification and antibiotic susceptibility testing, enabling faster and more effective treatment decisions in critical care. The company's mission is to help healthcare professionals act faster and smarter to save lives by transforming sepsis diagnosis and management.

Industries

biotechnology
health-care
hospital-650c
medical-device
venture-capital-b37d

Nr. of Employees

small (1-50)

Momentum Bioscience


Products

Automated direct-from-blood microbial detection and sample-preparation system

An automated system that extracts, concentrates and enriches viable organisms from whole blood, removes blood and antibiotics, performs PCR-based detection and molecular Gram delineation, and provides quantitative growth monitoring and an enumerated microbial suspension for downstream identification, phenotypic AST and NGS.


Services

Automated direct-from-blood sample processing and detection

Instrument-based processing service to extract, concentrate and enrich viable microbes from whole blood and provide integrated molecular detection and quantitative growth monitoring for downstream ID, AST and NGS workflows.

Expertise Areas

  • Bloodstream infection diagnostics
  • Direct-from-blood sample preparation
  • Rapid phenotypic antibiotic susceptibility testing workflows
  • Metagenomic sample preparation for clinical sequencing
  • Show More (3)

Key Technologies

  • PCR-based microbial detection
  • Quantitative growth monitoring
  • Automated sample preparation systems
  • Microbial extraction and enrichment from whole blood
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.